101 – 110 of 349
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
‘Stealth’ corporate innovation : an emerging threat for therapeutic drug development
- Contribution to journal › Debate/Note/Editorial
-
Mark
The Emergence of Hypervirulent M1T1 Clone of Group A Streptococcus via Genetic Recombination and Host Selection
- Contribution to journal › Article
-
Mark
C4BP-IgM protein as a therapeutic approach to treat Neisseria gonorrhoeae infections
- Contribution to journal › Article
-
Mark
High levels of cartilage oligomeric matrix protein in the serum of breast cancer patients can serve as an independent prognostic marker
- Contribution to journal › Article
-
Mark
A cryptic non-GPI-anchored cytosolic isoform of CD59 controls insulin exocytosis in pancreatic β-cells by interaction with SNARE proteins
(2019) In FASEB journal : official publication of the Federation of American Societies for Experimental Biology 33(11). p.12425-12434
- Contribution to journal › Article
- 2018
-
Mark
Overactivity of alternative pathway convertases in patients with complement-mediated renal diseases
- Contribution to journal › Article
-
Mark
Genetic predisposition to infection in a case of atypical hemolytic uremic syndrome
- Contribution to journal › Article
-
Mark
Complement C4d-specific antibodies for the diagnosis of lung cancer
- Contribution to journal › Article
-
Mark
Human igg increases virulence of streptococcus pyogenes through complement evasion
- Contribution to journal › Article
-
Mark
Novel potential inhibitors of complement system and their roles in complement regulation and beyond
- Contribution to journal › Article
